Itchy Palm: Zoom call did nothing to change there minds for the many shareholders I know
I think you're wrong. The call changed my mind.
I was under the impression Ms. Yeager might be qualified with her experience, despite not being a shareholder. But Gordon on our current BOD isn't a shareholder, so that's ok.
After the call it was evident Yeager lacks FDA knowledge and is "yeagerly" incompetent
The proxy group doesn't need someone knowledgeable when their goal is to sell IncellDx for $500M and dilute CYDY more than 30%.